UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF

THE SECURITIES EXCHANGE ACT OF 1934

 


 

T2 BIOSYSTEMS, INC.

(Exact name of registrant as specified in its charter)

 


 

Delaware

 

20-4827488

(State of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

101 Hartwell Avenue

 

 

Lexington, Massachusetts

 

02421

(Address of principal executive offices)

 

(Zip Code)

 


 

Securities to be registered pursuant to Section 12(b) of the Act:

 

 

 

Title of each class
to be so registered

 

Name of each exchange on which
each class is to be registered

Common stock, $0.001 par value per share

 

The NASDAQ Stock Market LLC

 


 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. o

 

Securities Act registration statement file number to which this form relates: 333-197193

 

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 



 

Item 1.        Description of Registrant’s Securities to be Registered.

 

The description of the Common Stock, par value $0.001 per share, of the Registrant set forth under the heading “Description of Capital Stock” in the prospectus included in the Registrant’s Registration Statement on Form S-1 (File No. 333-197193), as initially filed with the Securities and Exchange Commission on July 2, 2014 and as subsequently amended (the “Registration Statement”), is hereby incorporated by reference.  Any form of prospectus that constitutes part of the Registration Statement and is subsequently filed by the Registrant pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed incorporated by herein by reference.

 

Item 2.        Exhibits.

 

Pursuant to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

2



 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: July 25, 2014

T2 BIOSYSTEMS, INC.

 

 

 

By:

/s/ John McDonough

 

 

John McDonough

 

 

President and Chief Executive Officer

 

3